Resignation of CFO and appointment of CFO.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.2 pts more than Nifty Microcap 250 and 1.6 pts more than its Pharmaceuticals & Biotechnology peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
On January 19, 2026, the board of Genesis IBRC India Limited approved a sweeping leadership overhaul. Mr. CHDVV Prasad Rao resigned as CFO, citing change in management, change in control through open offer, and other professional commitments. Mr. Ravindranath Rajaram, a Chartered Accountant with 15+ years of experience, was appointed as the new CFO the same day. The company also appointed three new Non-Executive Directors and two Independent Directors for 5-year terms, while Ms. Poonam Chaturvedi was elevated to Managing Director for 1 year. Four existing directors — a Whole Time Director, a Non-Executive Director, and two Independent Directors — also resigned. The board additionally approved a proposed name change to CCME Global Limited (or CCME International/Worldwide Limited), subject to MCA and shareholder approval.
This is a significant governance overhaul coinciding with a change in control via open offer, suggesting a new promoter or acquirer is reshaping the company. Shareholders should watch for the open offer trigger event and the name change, as they signal a new strategic direction. The simultaneous exit of four directors and entry of new faces may create short-term uncertainty but could bring fresh management focus.